Sign in
Taking peopleNo phase

Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock

Key facts

Who runs it
Centre Hospitalier Intercommunal Creteil
Where
France33 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
820 people, planned
Started
1 Oct 2022
Expected to end
1 Dec 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • External Cooling
Record updated
21 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Documented or suspected infection either communautary or hospital acquired
  • Septic shock defined by the need for vasopressor and lactate>2 mmol/l despite adequate fluid resuscitation (sepsis-3 definition)
  • Patients under invasive mechanical ventilation
  • Body core temperature>38.3°C
  • Intravenous sedation or opioids
  • Ongoing antimicrobial treatment and/or intervention for infection source control
  • Attending physician confirms clinical equipoise without substantial risk if the patient participates in the trial
  • Informed consent of next of kin/other designated person before inclusion or procedure for inclusion in emergency situation

Who cannot take part

  • Cardiac arrest within previous 7 days
  • Acute brain injury within previous 7 days
  • <18 years old
  • Extensive burns or epidermal necrolysis
  • Body core temperature >41°C
  • Under legal guardianship
  • No affiliation with the French health-care system
  • Pregnancy
  • Participation in another interventional study with mortality as the primary endpoint
  • An investigator's decision not to resuscitate
  • Patient already recruited in the trial

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The best strategy for managing fever in patients with septic shock remains unknown. In a pilot study, the investigators showed that fever control at normothermia allowed a better control of shock and evolution of organ failures. In this second trial the investigators will conduct a multicentre, open-label, randomized controlled, superiority trial in which two strategies will be compared:

Read full original descriptionShow less

1. Respect of fever 2. Fever control at normothermia using external cooling The primary end point will be d-60 mortality.

The 2 groups in the trial

  • Fever Control by external coolingTreatment being tested

    External cooling during 48 hours to obtain normothermia

    Treatment: External Cooling

  • Fever respected, no coolingNo study treatment, for comparison

    Fever respect without any antipyretic therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique
Publications
Record updated
21 September 2026